Method for determining drug resistance mutations in any of the non-structural protein regions ns3 to ns5b of hepatitis c virus (hcv) for genotypes 1 to 6
EP2341343A1
Measurement system and method for determination and/or detection of one or more agents in one or more samples using said measurement system
EP2449489A1
Method for determining the efficacy of a combination therapy
AU2010247444A1
HIV-1-C resistance monitoring
CA2739532A1
Method for determining drug resistance mutations in any of the non-structural protein regions ns3 to ns5b of hepatitis c virus (hcv) for genotypes 1 to 6
WO2009115594A2
Genetic detection of hiv-1 strains that use the cxcr4 co-receptor
Computational method for predicting the contribution of mutations to the drug resistance phenotype exhibited by hiv based on a linear regression analysis of the log fold resistance
NZ528348A
Circular probe amplification (CPA) using closed circular padlock probe molecules and energy-transfer primers
CN1864163A
Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance
MXPA03003476A
New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance.
CA2425772A1
Establishment of biological cut-off values for predicting resistance to therapy
AU6752001A
Method and system for predicting therapeutic agent resistance and for defining the genetic basis of drug resistance using neural networks
CA2406830A1
Method for mutation detection in hiv using pol sequencing
US6800463B1
Method for mutation detection in HIV-1 using pol sequencing
